EXAS and Radient are unrelated, IMO. EXAS' test is for CRC only. Radient let their FDA clearance expire for CRC monitoring.
That must mean Radient does not care about CRC testing any more. Perhaps they intend to focus on lung cancer testing.
Unless you think it means Radient is basically defunct as a company and has no money to pay for ANYTHING, including the annual fees to keep FDA clearance active and Eurpoean patent applications. That's my personal opinion, but impossible to prove or disprove. Sort of like a rumor about MJ or a backdoor merger.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.